Tech Company Financing Transactions
Resilience Bio Funding Round
Resilience Bio, based in La Jolla, received $800 million from 8VC and Arch Venture Partners.
Transaction Overview
Company Name
Announced On
11/23/2021
Transaction Type
Venture Equity
Amount
$800,000,000
Round
Undisclosed
Investors
8VC (Drew Oetting)
Arch Venture Partners (Robert Nelsen)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Enterprise IT
Mailing Address
9310 Athena Circle
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Resilience is changing the way medicine is made -- leveraging innovation to better serve scientific discovery, withstand disruptive events, and reach those in need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Patrick Yang
Chief Executive Officer
Rahul Singhvi
Chief Scientific Officer
Richard Stoner
President
Sandy Mahatme
VP - General Counsel
Ori Solomon
VP - Manufacturing
James Miller
Browse more venture capital transactions:
Prev: 11/23/2021: Jina AI venture capital transaction
Next: 11/23/2021: Pace Enterprise venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs